Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Envoy Medical (COCH) Accumulated Depreciation & Amortization (2023 - 2025)

Envoy Medical's Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $5.1 million for Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization changed N/A year-over-year to $5.1 million; the TTM value through Sep 2025 reached $5.1 million, changed N/A, while the annual FY2024 figure was $4.8 million, 3.71% up from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2025 was $5.1 million at Envoy Medical, up from $4.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.1 million in Q3 2025 and bottomed at $4.7 million in Q4 2023.
  • The 3-year median for Accumulated Depreciation & Amortization is $4.8 million (2024), against an average of $4.8 million.
  • The largest YoY upside for Accumulated Depreciation & Amortization was 3.71% in 2024 against a maximum downside of 3.71% in 2024.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $4.7 million in 2023, then grew by 3.71% to $4.8 million in 2024, then increased by 4.6% to $5.1 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Accumulated Depreciation & Amortization are $5.1 million (Q3 2025), $4.8 million (Q4 2024), and $4.7 million (Q4 2023).